Bal Pharma Ltd.

BSE: 524824 | NSE: BALPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE083D01012 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Bal Pharma Ltd Bal Pharma Ltd. | BSE 73.59 0.34 (0.46%) | NSE 73.02 -0.30 (-0.41%) | Trade | Add

BSE Live

Jan 01, 16:01

73.59 0.34 (0.46%)

Volume

AVERAGE VOLUME

5-Day

4,294

10-Day

2,321

30-Day

1,815

Prev. Close

73.25
Open Price

72.11

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Jan 01, 15:41

73.02 -0.30 (-0.41%)

Volume

AVERAGE VOLUME

5-Day

9,390

10-Day

6,714

30-Day

8,270

2,557

Prev. Close

73.32
Open Price

71.50

Bid Price (Qty.)
73.02 (10)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Balance Sheet of Bal Pharma (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	15.92	15.80	15.69	14.82	14.82
Total Share Capital	15.92	15.80	15.69	14.82	14.82
Reserves and Surplus	61.50	53.49	48.10	42.87	37.82
Total Reserves and Surplus	61.50	53.49	48.10	42.87	37.82
Total Shareholders Funds	77.42	69.29	63.79	58.63	53.58
Minority Interest	-0.01	-0.03	-0.09	-0.13	-0.23
NON-CURRENT LIABILITIES
Long Term Borrowings	31.40	36.35	30.52	27.01	23.93
Deferred Tax Liabilities [Net]	0.00	3.96	2.87	0.60	2.63
Other Long Term Liabilities	1.74	1.83	1.68	4.08	3.56
Long Term Provisions	5.64	5.09	5.07	4.69	4.07
Total Non-Current Liabilities	38.79	47.22	40.14	36.40	34.19
CURRENT LIABILITIES
Short Term Borrowings	118.98	103.25	100.48	70.75	80.82
Trade Payables	81.69	77.46	78.92	65.56	47.17
Other Current Liabilities	17.67	21.38	29.30	28.60	23.89
Short Term Provisions	1.17	0.95	0.64	0.73	0.66
Total Current Liabilities	219.50	203.04	209.33	165.64	152.53
Total Capital And Liabilities	335.69	319.53	313.17	260.53	240.08
ASSETS
NON-CURRENT ASSETS
Tangible Assets	70.99	61.61	62.18	55.57	57.51
Intangible Assets	12.00	11.38	10.46	7.99	7.25
Capital Work-In-Progress	2.79	0.47	0.00	1.61	0.00
Fixed Assets	85.77	73.46	72.64	65.18	64.76
Non-Current Investments	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets [Net]	0.41	2.41	2.17	0.00	0.00
Long Term Loans And Advances	0.00	0.12	0.10	0.40	0.38
Other Non-Current Assets	10.81	5.56	6.29	6.56	6.96
Total Non-Current Assets	100.82	85.38	85.02	75.96	75.93
CURRENT ASSETS
Current Investments	2.47	6.76	0.00	0.00	0.00
Inventories	103.02	87.81	98.01	74.40	60.39
Trade Receivables	92.44	99.62	93.98	75.31	67.20
Cash And Cash Equivalents	8.05	13.29	7.61	5.39	3.85
Short Term Loans And Advances	1.13	1.37	0.96	2.37	2.06
OtherCurrentAssets	27.76	25.30	27.60	27.10	30.65
Total Current Assets	234.87	234.15	228.16	184.57	164.15
Total Assets	335.69	319.53	313.17	260.53	240.08
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	17.10	16.96	0.00	0.00	4.34
BONUS DETAILS
Bonus Equity Share Capital	3.04	3.04	3.04	3.04	3.04
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	0.00	0.00	0.00	0.00	0.00
Non-Current Investments Unquoted Book Value	0.00	0.00	0.00	0.00	0.00
CURRENT INVESTMENTS
Current Investments Quoted Market Value	0.00	0.00	0.00	0.00	0.00
Current Investments Unquoted Book Value	0.00	0.00	0.00	0.00	0.00